InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by King Andrew James, Directeur Scientifique. Director active across 2 companies, notably Chinook Therapeutics, INC.. In total, 16 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €29k. History available since 9 November 2021. The latest transaction was filed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to King Andrew James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
41,250 股0Common StockSEC:0001193125-26-052053:0
19,157 股Common StockSEC:0001209191-23-045424:0
3,333 股Common StockSEC:0001209191-23-044071:0
2,500 股@ US$0.352.0% 占其流量Common StockSEC:0001209191-23-023351:0
6,803 股Common StockSEC:0001209191-23-009766:0
8,333 股Common StockSEC:0001209191-23-006371:0
7,500 股@ US$0.356.2% 占其流量Common StockSEC:0001209191-23-001434:0
10,152 股Common StockSEC:0001209191-22-053301:0
5,000 股@ US$0.354.3% 占其流量Common StockSEC:0001209191-22-044596:0
5,000 股@ US$0.354.4% 占其流量Common StockSEC:0001209191-22-042041:0
5,000 股@ US$0.354.2% 占其流量Common StockSEC:0001209191-22-024324:0
2,500 股@ US$13.0074.4% 占其流量Common StockSEC:0001209191-22-012315:0
6,801 股Common StockSEC:0001209191-22-009564:0
2,500 股@ US$0.352.0% 占其流量Common StockSEC:0001209191-22-008937:0
2,500 股@ US$0.352.0% 占其流量Common StockSEC:0001209191-21-064363:0
10,151 股Common StockSEC:0001209191-21-060112:0
16 条申报中的 16 条
About King Andrew James
King Andrew James is Chief Scientific Officer. The declarant has 16 filings in total, and across the recent filings available from 2021-10-08 to 2026-02-13, sales total EUR 28593 and purchases EUR 0, with Levée d'options being the most frequent transaction type.
